The npj Regenerative Medicine impact factor sits between 6.5 and 7.0 in 2026, depending on the source. This article breaks down where those figures come from and what the number can and can't tell you about individual studies or clinical claims.

Just hurt your shoulder? This 2026 guide walks you through rotator cuff injury treatment at home, from the first critical hours to spotting the warning signs of a true tear. Learn evidence-based first aid and a simple self-triage system to know when professional care is needed.

Stroke survivors often hit a rehab plateau long before full recovery, leading many to explore stem cell therapy stroke options. This 2026 guide breaks down the neuroplasticity window framework, current clinical trial evidence, and how to distinguish credible research from predatory clinics.

Not all partial rotator cuff tears are equal candidates for stem cell therapy. This article breaks down how Ellman grade and tear chronicity create a narrowing biological window, offering a smarter framework than the outdated partial-vs-full tear rule for evaluating rotator cuff tear stem cell therapy in 2026.

Success rates for physical therapy treatment for rotator cuff injury range from 33% to over 90%—and the difference isn't random. This 2026 framework breaks down tear thickness, size, fatty infiltration, age, and vascularity to show where patients actually fall on the outcomes spectrum and when biology, not effort, becomes the limiting factor.

Curious what the npj Regenerative Medicine impact factor actually signals about credibility? This 2026 guide breaks down the journal's 6.5 Impact Factor and 10.5 CiteScore in plain language, explaining why the numbers shifted and what truly matters when evaluating a cited study.